Journal article

TNF as a therapeutic target

Abstract:: Tumor necrosis factor α (TNF-α) is a well-recognized proinflammatory cytokine, and as such provides an ideal target for anti-inflammatory therapies. Recent developments have shown very exciting results, and in this article, Jan Bondeson, Marc Feldman, and Ravinder N. Maini review the outcome of clinical trials of anti-TNF-α therapies in a range of chronic inflammatory diseases.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Bondeson, J., Feldmann, M., & Maini, R. (2000). TNF as a therapeutic target. IMMUNOLOGIST, 8(6), 136–140.

MLA Style

Bondeson, J, et al. “TNF as a Therapeutic Target.” IMMUNOLOGIST, vol. 8, no. 6, 2000, pp. 136–40.

Chicago Style

Bondeson, J, M Feldmann, and R Maini. 2000. “TNF as a Therapeutic Target.” IMMUNOLOGIST 8 (6): 136–40.
Print

Authors

+ Bondeson, J More by this author

Role:: Author

+ Feldmann, M More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Role:: Author

+ Maini, R More by this author

Role:: Author

Journal:: IMMUNOLOGIST More from this journal
Volume:: 8
Issue:: 6
Pages:: 136-140
Publication date:: 2000-01-01
ISSN:: 1192-5612

Language:: English
Pubs id:: pubs:226139
UUID:: uuid:153f1289-18a0-4e0f-a471-bc6650fe19b3
Local pid:: pubs:226139
Source identifiers:: 226139
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_153f128918a04e0fa471bc6650fe19b3

Terms of use

Copyright date:: 2000

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP